Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMER.L Regulatory News (AMER)

  • There is currently no data for AMER

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

20 Jan 2012 07:00

RNS Number : 8890V
Amerisur Resources PLC
20 January 2012
 



20 January 2012

 

Amerisur Resources Plc ("Amerisur" or the "Company")

 

Grant of Share Options 

Amerisur Resources Plc, the oil and gas producer and explorer focused on South America, announces that on 19 January 2012 the Company's Remuneration Committee ("the Committee") which is comprised wholly of non-executive directors, granted options to directors and employees over 9,485,000 new ordinary shares of 0.1p each, representing 1.0 per cent of the current issued share capital, under the Long Term Incentive Plan ("LTIP") approved at the 2011 AGM. The Committee designed the LTIP in accordance with current best practice and with the intention of delivering appropriate awards to senior management on the delivery of exceptional corporate performance.

The LTIP is a new "longer-term" incentive plan replacing the old option scheme. It represents a key change to the current remuneration structure for the directors and, equally importantly, for those more junior members of Amerisur's management team, who are making important contributions to the creation of shareholder value who have been included in this award as indeed they were in the previous scheme.

The options are nil cost options which are eligible to vest over a three year period ("Vesting Period") subject to achieving performance levels which create value for shareholders. Vesting is on a sliding scale which depends upon the effective shareholder return during the Vesting Period:

Total Shareholder Return (p.a.) Level of Vesting (%)

20% (73% compound over three years) 100%

15% (52% compound over three years) 65%

10% (33% compound over three years) 35%

The total shareholder return ("TSR") target is calculated from a base price of the average closing share price in the 30 day period prior to the date of award, which was 17.38p. Options will vest during the Vesting Period when any of the three percentage thresholds for 3 year TSR is achieved for a 30 day period based on the average closing share price for that period.

 

There was no consideration paid upon the grant of the options and the options expire on the fifth anniversary of the grant.

8,250,000 options have been granted to Directors as follows:

Director

Number of options granted

Total options following this grant

John Wardle*

3,750,000

30,250,000

Giles Clarke

1,500,000

30,600,000

Nick Harrison

1,500,000

18,720,000

Victor Valdovinos

500,000

2,500,000

Douglas Ellenor

500,000

2,450,000

George Woodcock

500,000

500,000

 

* Dr Wardle's interests in his share options are held through his interest in Tracarta Ltd

 

 

ENQUIRIES:

 

Billy Clegg/Caroline Stewart,

FTI Consulting

Tel: +44 (0)207 831 3113

 

 

Martin Eales/Pierre Schreuder

RBC Capital Markets

 

Tel: +44 (0)207 653 4000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBLMJTMBJBTRT
Date   Source Headline
5th Feb 20187:00 amRNSMonthly Production, OBA and Operational Update
22nd Jan 20187:00 amRNSEcuador Update
4th Jan 20187:00 amRNSMonthly Production, OBA and Operational Update
18th Dec 20171:30 pmRNSNotification of major holdings
14th Dec 20177:00 amRNSPlatanillo-27 Update
4th Dec 20177:00 amRNSMonthly Production, OBA and Operational Update
1st Dec 20174:41 pmRNSSecond Price Monitoring Extn
1st Dec 20174:36 pmRNSPrice Monitoring Extension
1st Dec 20177:00 amRNSBlock Listing Six Monthly Return
21st Nov 20177:00 amRNSOperational Update - CPO-5
13th Nov 20177:00 amRNSOperations Update
6th Nov 20177:00 amRNSMonthly Production, OBA and Operational Update
31st Oct 20179:24 amRNSDirector Share Dealing
27th Oct 20173:51 pmRNSCPO-5 Update
26th Oct 20177:00 amRNSPlatanillo-25 Update
24th Oct 201710:15 amRNSDirector Share Dealing
19th Oct 20177:00 amRNSOperational Update
18th Oct 20173:16 pmRNSBlock Listing Six Monthly Return
12th Oct 201712:22 pmRNSNotification of Major Shareholdings
2nd Oct 20177:00 amRNSMonthly Production, OBA and Operational Update
26th Sep 20179:26 amRNSDirector Share Dealing
25th Sep 20173:35 pmRNSDirector Share Dealing
25th Sep 20177:00 amRNSInterim Results
20th Sep 20175:48 pmRNSTR-1 Notification of Major Holdings
4th Sep 20177:00 amRNSMonthly Production and OBA Throughput Update
24th Aug 20177:00 amRNSNotice of Interim Results
9th Aug 20177:00 amRNSMariposa-1 Update CPO-5 Block
3rd Aug 20177:00 amRNSOperational Update
5th Jul 20177:00 amRNSMonthly Production, OBA and Operations Update
15th Jun 20177:00 amRNSPlatanillo Operations Update
12th Jun 20177:00 amRNSMonthly Production and OBA Throughput Update
30th May 20177:00 amRNSMariposa-1 Update CPO-5 Block
25th May 20177:00 amRNSPlatanillo-21 Update
9th May 201712:33 pmRNSResult of AGM
9th May 20179:30 amRNSAGM Statement
8th May 20177:00 amRNSAppointment of Senior Independent Director
4th May 20172:25 pmRNSSuccessful drilling at CPO-5 Block - Llanos Basin
4th May 20177:00 amRNSPlatanillo Operations Update
2nd May 20177:00 amRNSMonthly Production and OBA Throughput Update
25th Apr 20175:59 pmRNSHolding(s) in Company
21st Apr 20178:34 amRNSAGM Statement (Replacement)
21st Apr 20177:00 amRNSOperations Update - Platanillo-21 Spudded
20th Apr 20176:29 pmRNSNotice of Annual General Meeting
20th Apr 20177:00 amRNSOperations Update
10th Apr 20177:00 amRNSFinal Results for the year ended 31 December 2016
6th Apr 20177:00 amRNSAppointment of independent non-executive Director
4th Apr 20177:00 amRNSMonthly Production and OBA Throughput Update
30th Mar 201710:35 amRNSPlatanillo-22 Update
27th Mar 20177:00 amRNSColombia Operations Update
23rd Mar 20178:13 amRNSReserves & Resources Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.